- Home
- Publications
- Publication Search
- Publication Details
Title
Conventional type 1 dendritic cells (cDC1) in cancer immunity
Authors
Keywords
-
Journal
Biology Direct
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-01
DOI
10.1186/s13062-023-00430-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Calreticulin exposure orchestrates innate immunosurveillance
- (2023) Emma Guilbaud et al. CANCER CELL
- Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer
- (2023) Colt A. Egelston et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune checkpoint therapy—current perspectives and future directions
- (2023) Padmanee Sharma et al. CELL
- Apoptotic cell death in disease—Current understanding of the NCCD 2023
- (2023) Ilio Vitale et al. CELL DEATH AND DIFFERENTIATION
- Immunogenic cell death in cancer: concept and therapeutic implications
- (2023) Lorenzo Galluzzi et al. Journal of Translational Medicine
- Neoadjuvant immunotherapy for melanoma is now ready for clinical practice
- (2023) Claus Garbe et al. NATURE MEDICINE
- A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity
- (2023) Philippa Meiser et al. CANCER CELL
- The BCL2 inhibitor venetoclax mediates anticancer effects through dendritic cell activation
- (2023) Peng Liu et al. CELL DEATH AND DIFFERENTIATION
- First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial
- (2023) Marion Thibaudin et al. NATURE MEDICINE
- BCL2 Inhibition Reveals a Dendritic Cell–Specific Immune Checkpoint That Controls Tumor Immunosurveillance
- (2023) Liwei Zhao et al. Cancer Discovery
- A Chemically Defined TLR3 Agonist with Anticancer Activity
- (2023) Julie Le Naour et al. OncoImmunology
- Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
- (2023) Shuai Zhang et al. Journal for ImmunoTherapy of Cancer
- Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell–NK cell axis in murine hepatocellular carcinoma model
- (2022) Shuai Wang et al. JOURNAL OF HEPATOLOGY
- Human dendritic cells in cancer
- (2022) Egle Kvedaraite et al. Science Immunology
- PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
- (2022) Peng Liu et al. OncoImmunology
- Depletion of conventional type-1 dendritic cells in established tumors suppresses immunotherapy efficacy
- (2022) Alvaro Teijeira et al. CANCER RESEARCH
- Loss of secreted gelsolin enhances response to anticancer therapies
- (2022) Kok Haw Jonathan Lim et al. Journal for ImmunoTherapy of Cancer
- Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
- (2022) Andreas Hagen Røssevold et al. NATURE MEDICINE
- Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment
- (2022) Nicolas Roussot et al. Cells
- Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy
- (2021) Anastasia Prokopi et al. Journal for ImmunoTherapy of Cancer
- The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake
- (2021) Álvaro de Mingo Pulido et al. IMMUNITY
- Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer
- (2021) Christopher S. Garris et al. Science Translational Medicine
- TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses
- (2021) Nicoletta Caronni et al. Nature Communications
- Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model
- (2021) Yoke Seng Lee et al. Journal for ImmunoTherapy of Cancer
- DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells
- (2021) Francisco J Cueto et al. Journal for ImmunoTherapy of Cancer
- Mevalonate Blockade in Cancer Cells Triggers CLEC9A+ Dendritic Cell-Mediated Antitumor Immunity
- (2021) Feifei Xu et al. CANCER RESEARCH
- Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity
- (2021) Evangelos Giampazolias et al. CELL
- Metabolomic and lipidomic signatures associated with activation of human cDC1 (BDCA3 + /CD141 + ) dendritic cells
- (2021) Farhan Basit et al. IMMUNOLOGY
- Countering the advert effects of lung cancer on the anticancer potential of dendritic cell populations reinstates sensitivity to anti-PD-1 therapy
- (2021) Julyanne Brassard et al. PLoS One
- Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
- (2020) José Trigo et al. LANCET ONCOLOGY
- A conserved dendritic-cell regulatory program limits antitumour immunity
- (2020) Barbara Maier et al. NATURE
- Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+conventional dendritic cells
- (2020) Yifan Zhou et al. Journal for ImmunoTherapy of Cancer
- Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer
- (2020) Beatris Mastelic-Gavillet et al. EUROPEAN JOURNAL OF CANCER
- Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy
- (2020) Takahiro Yamazaki et al. NATURE IMMUNOLOGY
- The Superior Ability of Human BDCA3+ (CD141+) Dendritic Cells (DCs) to Cross-Present Antigens Derived From Necrotic Lung Cancer Cells
- (2020) Fei-fei Gu et al. Frontiers in Immunology
- A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency
- (2020) Julie Le Naour et al. Cancer Discovery
- Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy
- (2019) Bernardo Rapoport et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
- (2019) Stefanie K. Wculek et al. Journal for ImmunoTherapy of Cancer
- Immunology of Plasmacytoid Dendritic Cells in Solid Tumors: A Brief Review
- (2019) Vladimír Koucký et al. Cancers
- Plasmacytoid dendritic cells develop from Ly6D+ lymphoid progenitors distinct from the myeloid lineage
- (2019) Regine J. Dress et al. NATURE IMMUNOLOGY
- Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
- (2018) Flavia Radogna et al. BIOCHEMICAL PHARMACOLOGY
- TIM-3 Regulates CD103 + Dendritic Cell Function and Response to Chemotherapy in Breast Cancer
- (2018) Álvaro de Mingo Pulido et al. CANCER CELL
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Immune Checkpoint Blockade across the Cancer Care Continuum
- (2018) Beth A. Helmink et al. IMMUNITY
- Tumor-Resident Dendritic Cells and Macrophages Modulate the Accumulation of TCR-Engineered T Cells in Melanoma
- (2018) Alastair Hotblack et al. MOLECULAR THERAPY
- Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
- (2018) Paula Michea et al. NATURE IMMUNOLOGY
- Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells
- (2018) Patrick Fernandes Rodrigues et al. NATURE IMMUNOLOGY
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
- (2018) Melissa A. Meyer et al. Nature Communications
- TFAM is a novel mediator of immunogenic cancer cell death
- (2018) Minghua Yang et al. OncoImmunology
- Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus–Derived Vectors Fosters Dendritic Cell–Mediated T-cell Cross-Priming
- (2018) Alfonso R. Sánchez-Paulete et al. CANCER RESEARCH
- Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy
- (2018) Jing Liu et al. OncoImmunology
- Mapping the human DC lineage through the integration of high-dimensional techniques
- (2017) Peter See et al. SCIENCE
- Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
- (2017) Alexandra-Chloé Villani et al. SCIENCE
- Transcriptional Control of Dendritic Cell Development
- (2016) Theresa L. Murphy et al. Annual Review of Immunology
- Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients
- (2016) J. Fucikova et al. BLOOD
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- Damage-associated molecular patterns in cancer: a double-edged sword
- (2016) C Hernandez et al. ONCOGENE
- Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103+ dendritic cells in late-stage ovarian cancer
- (2016) Dallas B. Flies et al. OncoImmunology
- Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer
- (2016) Gautier Stoll et al. OncoImmunology
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
- (2015) E. Vacchelli et al. SCIENCE
- Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
- (2015) A. R. Sanchez-Paulete et al. Cancer Discovery
- CD103+ Dendritic Cells Producing Interleukin-12 in Anticancer Immunosurveillance
- (2014) Laurence Zitvogel et al. CANCER CELL
- Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
- (2014) Brian Ruffell et al. CANCER CELL
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
- (2013) Miriam Merad et al. Annual Review of Immunology
- Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
- (2013) Yuting Ma et al. IMMUNITY
- Generation of Inducible Immortalized Dendritic Cells with Proper Immune Function In Vitro and In Vivo
- (2013) Cornelia Richter et al. PLoS One
- DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues
- (2012) L. F. Poulin et al. BLOOD
- Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
- (2012) L. Menger et al. Science Translational Medicine
- Cutting Edge: Expression of XCR1 Defines Mouse Lymphoid-Tissue Resident and Migratory Dendritic Cells of the CD8 + Type
- (2011) K. Crozat et al. JOURNAL OF IMMUNOLOGY
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
- (2010) M Wemeau et al. Cell Death & Disease
- The anticancer immune response: indispensable for therapeutic success?
- (2008) Laurence Zitvogel et al. JOURNAL OF CLINICAL INVESTIGATION
- Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset
- (2008) M. L. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now